Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, affects nerve cells in the brain and spinal cord, called motor neurons, that control voluntary muscle movements like walking, talking, and breathing. As the neurons die and can’t send messag… Continue reading Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials